So far Monday, November 2, NASDAQ is down -4.32% and the S&P is down -1.05%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Virnetx Holding (VHC – Research Report), Marathon Petroleum (MPC –
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Karyopharm Therapeutics (KPTI – Research Report) and Acasti Pharma (ACST – Research Report). Karyopharm Therapeutics (KPTI) Barclays analyst Peter Lawson maintained a Buy
So far Sunday, May 24, NASDAQ is up 1.15% and the S&P is up 0.89%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Amarin (AMRN – Research Report), Virnetx Holding (VHC – Research
H.C. Wainwright analyst Edward White reiterated a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) on May 20 and set a price target of $40.00. The company’s shares closed last Friday at $20.65. According to TipRanks.com, White is a
So far Wednesday, May 20, NASDAQ is up 2.49% and the S&P is up 1%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Goodrich Petroleum (GDP – Research Report), SunPower (SPWR – Research
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Karyopharm Therapeutics (KPTI – Research Report), aTyr Pharma (LIFE – Research Report) and Arvinas Holding Company (ARVN – Research Report). Karyopharm Therapeutics (KPTI)